University of Bordeaux, Institute of Health and Medical Research, Bordeaux Population Health Research Center, UMR1219, Bordeaux, France.
Pediatric Nephrology Unit, Pellegrin-Enfants Hospital, Bordeaux University Hospital, Centre de Référence Maladies Rénales Rares Sorare, Bordeaux, France.
Transplantation. 2022 Feb 1;106(2):401-411. doi: 10.1097/TP.0000000000003757.
Kidney transplantation (KT) is the optimal treatment for children with end-stage kidney disease. The aim of this study was to evaluate the impact of preemptive kidney transplantation (PKT) and of pretransplant dialysis duration on graft survival among French pediatric kidney transplant recipients.
We analyzed all first pediatric kidney-only transplantations performed in France between 1993 and 2012. A Cox multivariable model was used to investigate the association of PKT and pretransplant dialysis time with the hazard of graft failure defined as death, return to dialysis, or retransplant, whichever occurred first.
Patients (n = 1911) were included, of which 380 (19.8%) received a PKT. Median time of follow-up was 7.0 y. PKT was associated with a 55% reduction of the hazard of graft failure at any time after KT compared with patients transplanted after dialysis (hazard ratio, 0.45; 95% confidence interval, 0.33-0.62), after adjustment for recipient sex and age, primary kidney disease, donor age and type (living or deceased donor), number of HLA mismatches, cold ischemia time, and year of transplantation. A reduction of the hazard of graft failure was found in PKT whatever the compared duration of dialysis, even when <6 mo and whatever the dialysis modality. Results were similar in multiple sensitivity analyses.
In France, PKT among pediatric patients is associated with a better graft survival when compared with KT after dialysis, even when <6 mo. Based on these findings, we suggest that PKT should be considered as the treatment of choice for children with end-stage kidney disease.
肾移植(KT)是治疗终末期肾病儿童的最佳方法。本研究旨在评估法国儿科肾移植受者中抢先性肾移植(PKT)和移植前透析时间对移植物存活率的影响。
我们分析了 1993 年至 2012 年期间在法国进行的所有首次儿科肾单器官移植。使用 Cox 多变量模型来研究 PKT 和移植前透析时间与移植物衰竭的风险之间的关联,移植物衰竭定义为死亡、返回透析或再次移植,以先发生者为准。
共纳入 1911 例患者,其中 380 例(19.8%)接受 PKT。中位随访时间为 7.0 年。与透析后移植的患者相比,PKT 可使任何时间发生的移植物衰竭风险降低 55%(风险比,0.45;95%置信区间,0.33-0.62),校正受者性别和年龄、原发病、供者年龄和类型(活体或已故供者)、HLA 错配数、冷缺血时间和移植年份后。无论透析时间长短,即使<6 个月,无论透析方式如何,PKT 均可降低移植物衰竭的风险。在多次敏感性分析中,结果均相似。
在法国,与透析后进行 KT 相比,儿科患者的 PKT 与更好的移植物存活率相关,即使<6 个月。基于这些发现,我们建议 PKT 应被视为终末期肾病儿童的首选治疗方法。